EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access

Impact of the Cardio-Meds Mobile App on Heart Failure Knowledge and Medication Adherence: Pilot Randomized Controlled Trial

Victor Buswell iD, Emmanuelle Massie iD, Elena Tessitore iD, Lisa Simioni iD, Guillaume Guebey iD, Hamdi Hagberg iD, Aurélie Schneider-Paccot iD, Samaksha Pant iD, Katherine Blondon iD, Liliane Gschwind iD, Frederic Ehrler iD, Philippe Meyer iD

JMIR Cardio · 2026

DOI: 10.2196/83022 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift JMIR Cardio, 2026. Verfasst von Victor Buswell und 11 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine, University of Geneva, Geneva, Switzerland. Hauptthemen laut MEDLINE: Adherence Interventions, Health Knowledge, Attitudes, Practice, Heart Failure, Medication Adherence. Die Arbeit nennt 26 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Heart failure (HF) is a prevalent chronic condition for which optimal management depends not only on guideline-directed medical therapy but also on patients’ understanding of their disease, recognition of warning signs, and sustained medication adherence, which remains challenging in routine care. Mobile health interventions may support therapeutic education and self-management; however, many available apps lack validated content and local relevance. Cardio-Meds is a mobile app developed at Geneva University Hospitals to support HF self-management through structured educational content, interactive quizzes, medication lists with reminders, and tools for monitoring weight and vital signs.

Objective

This study aims to evaluate the impact of a 30-day Cardio-Meds intervention on HF knowledge and medication adherence in patients with HF with reduced or mildly reduced ejection fraction.

Methods

We conducted a single-center, pilot randomized controlled trial in patients followed at the outpatient HF clinic or enrolled in cardiac rehabilitation at Geneva University Hospitals in 2024. Eligible participants had HF with a left ventricular ejection fraction less than 50%, were receiving HF-specific pharmacotherapy, speak French, and owned a smartphone. Participants were recruited by phone and randomized to Cardio-Meds use for 30 days, a self-guided intervention with a single standardized technical support call. Outcomes were self-assessed using standardized questionnaires: HF knowledge and self-management using the Dutch Heart Failure Knowledge Scale (DHFKS; score range 0‐15); medication adherence using the Basel Assessment of Adherence to Immunosuppressive Medication Scale, covering initiation, implementation, and persistence; and usability in the intervention group using the System Usability Scale (score range 0‐100). Between-group differences in DHFKS scores were analyzed using analysis of covariance adjusted for baseline values.

Results

A total of 49 participants were included (25 intervention, 24 control); 78% (n=38) were male, and the mean age was 62 (SD 11.4) years. In the intervention group, median app usage was 123 (IQR 74‐273) minutes, with a median of 43 (IQR 19‐85) logins. Mean baseline DHFKS scores were similar between groups (intervention 11.1, SD 2.4 vs control 10.5, SD 2.9). At 30 days, mean scores increased significantly in the intervention group (12.4, SD 2.4; mean change +1.3; P

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Adherence InterventionsHealth Knowledge, Attitudes, PracticeHeart FailureMedication AdherenceMobile ApplicationsPatient Education as TopicAgedFemaleHumansMaleMiddle AgedPilot ProjectsTelemedicine

Stichwörter der Autor:innen

digital health interventionheart failuremHealthmedication adherencemobile healthpatient educationrandomized controlled trial

Autor:innen und Institutionen

  • Faculty of Medicine, University of Geneva, Geneva, Switzerland.
  • Heart Failure and Cardiovascular Rehabilitation Unit, Cardiology Service, Geneva University Hospitals, Rue Gabrielle Perret-Gentil 4, Geneva, 1205, Switzerland, (+41) 22 372 13 13, (+41) 22 372 37 45.
  • Computer Science Department, University Hospital of Geneva, Geneva, Switzerland.
  • Cardiology Division, Hôpital de la Tour, Meyrin, Switzerland.
  • Medical Directorate, University Hospital of Geneva, Geneva, Switzerland.
  • Pharmacy Department, University Hospital of Geneva, Geneva, Switzerland.

ORCID-Profile: Victor Buswell, Emmanuelle Massie, Elena Tessitore, Lisa Simioni, Guillaume Guebey, Hamdi Hagberg, Aurélie Schneider-Paccot, Samaksha Pant, Katherine Blondon, Liliane Gschwind, Frederic Ehrler, Philippe Meyer

Zitieren

APA

Buswell, V., Massie, E., Tessitore, E., Simioni, L., Guebey, G., Hagberg, H., Schneider-Paccot, A., Pant, S., Blondon, K., Gschwind, L., Ehrler, F., & Meyer, P. (2026). Impact of the Cardio-Meds Mobile App on Heart Failure Knowledge and Medication Adherence: Pilot Randomized Controlled Trial. JMIR Cardio. https://doi.org/10.2196/83022

Vancouver

Buswell V, Massie E, Tessitore E, Simioni L, Guebey G, Hagberg H, et al. Impact of the Cardio-Meds Mobile App on Heart Failure Knowledge and Medication Adherence: Pilot Randomized Controlled Trial. JMIR Cardio. 2026. doi:10.2196/83022

BibTeX
@article{Buswell2026,
  author = {Buswell, Victor and Massie, Emmanuelle and Tessitore, Elena and Simioni, Lisa and Guebey, Guillaume and Hagberg, Hamdi and Schneider-Paccot, Aurélie and Pant, Samaksha and Blondon, Katherine and Gschwind, Liliane and Ehrler, Frederic and Meyer, Philippe},
  title = {Impact of the Cardio-Meds Mobile App on Heart Failure Knowledge and Medication Adherence: Pilot Randomized Controlled Trial},
  journal = {JMIR Cardio},
  year = {2026},
  doi = {10.2196/83022}
}
Kostenlos starten →